Skip to main content

Table 3 Tumor diameters and the residual liver volume between DEB-TACE and cTACE

From: Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients

Parameter

DEB-TACE (N = 15)

cTACE (N = 8)

p-value

Tumor diameters (cm)

 Before treatment

9.4 ± 3.3

9.7 ± 2.6

0.826

 After treatment

Residual liver volume

5.4 ± 3.5

6.9 ± 2.2

0.209

 Before treatment

1066.2 ± 294.2

1046.4 ± 159.2

0.862

 After treatment

1180.3 ± 319.4

1074.0 ± 137.8

0.383

  1. Comparison was determined by unpaired-sample t-test